1. Home
  2. VIVS vs WTO Comparison

VIVS vs WTO Comparison

Compare VIVS & WTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • WTO
  • Stock Information
  • Founded
  • VIVS 2007
  • WTO 2008
  • Country
  • VIVS United States
  • WTO China
  • Employees
  • VIVS N/A
  • WTO N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • WTO Consumer Electronics/Appliances
  • Sector
  • VIVS Health Care
  • WTO Technology
  • Exchange
  • VIVS Nasdaq
  • WTO Nasdaq
  • Market Cap
  • VIVS 8.1M
  • WTO 8.0M
  • IPO Year
  • VIVS N/A
  • WTO 2021
  • Fundamental
  • Price
  • VIVS $2.28
  • WTO $0.05
  • Analyst Decision
  • VIVS
  • WTO
  • Analyst Count
  • VIVS 0
  • WTO 0
  • Target Price
  • VIVS N/A
  • WTO N/A
  • AVG Volume (30 Days)
  • VIVS 1.4M
  • WTO 69.3M
  • Earning Date
  • VIVS 11-12-2025
  • WTO 11-18-2025
  • Dividend Yield
  • VIVS N/A
  • WTO N/A
  • EPS Growth
  • VIVS N/A
  • WTO N/A
  • EPS
  • VIVS N/A
  • WTO N/A
  • Revenue
  • VIVS $142,000.00
  • WTO $34,589,265.00
  • Revenue This Year
  • VIVS $42.38
  • WTO N/A
  • Revenue Next Year
  • VIVS $15.42
  • WTO N/A
  • P/E Ratio
  • VIVS N/A
  • WTO N/A
  • Revenue Growth
  • VIVS 94.52
  • WTO 54.01
  • 52 Week Low
  • VIVS $1.41
  • WTO $0.04
  • 52 Week High
  • VIVS $21.96
  • WTO $4.40
  • Technical
  • Relative Strength Index (RSI)
  • VIVS 43.02
  • WTO 17.12
  • Support Level
  • VIVS $2.05
  • WTO $0.04
  • Resistance Level
  • VIVS $3.20
  • WTO $0.06
  • Average True Range (ATR)
  • VIVS 0.31
  • WTO 0.01
  • MACD
  • VIVS -0.02
  • WTO 0.01
  • Stochastic Oscillator
  • VIVS 20.00
  • WTO 10.57

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

Share on Social Networks: